Zobrazeno 1 - 10
of 62
pro vyhledávání: '"González Granado, LI."'
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
Autor:
Alsina L, Montoro JB, Moral PM, Neth O, Pica MO, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MÁ, González-Granado LI
Publikováno v:
EUROPEAN JOURNAL OF HEALTH ECONOMICS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Primary immunodeficiency diseases (PID), which are comprised of over 400 genetic disorders, occur when a component of the immune system is diminished or dysfunctional. Patients with PID who require immunoglobulin (IG) replacement therapy receive intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::e075df8ffdd345de1b2a511bc0eb3a0e
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20118
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20118
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Biallelic variants in genes previously associated with dominant inheritance: CACNA1A, RETand SLC20A2
Autor:
Arteche-López, A., Álvarez-Mora, MI., Sánchez Calvin, MT., Lezana Rosales, JM., Palma Milla, C., Gómez Rodríguez, M. J., Gomez Manjón, I., Blázquez, A., Juarez Rufián, A., Ramos Gómez, P., Sierra Tomillo, O., Hidalgo Mayoral, I., Pérez de la Fuente, R., Posada Rodríguez, IJ., González Granado, LI., Martin, Miguel A., Quesada-Espinosa, JF., Moreno-García, M.
Publikováno v:
European Journal of Human Genetics: EJHG; 20210101, Issue: Preprints p1-7, 7p
Autor:
Sanchez-Ramon, Silvia, Bermudez, Arancha, Ignacio Gonzalez-Granado, Luis, Rodriguez-Gallego, Carlos, Sastre, Ana, Soler-Palacin, Pere, Alonso, Laura, Allende, Luis, Alsina, Laia, Maria Bielsa, Ana, Calleja-Antolin, Sara, Camara, Carmen, Carbone, Javier, Carreras, Carmen, De Andres Martin, Ana, Deya, Angela, Diaz de Heredia, Cristina, Dieli-Crimi, Romina, Luis Diez, Jose, Dominguez-Pinilla, Nerea, Fernandez-Pereira, Luis, Ma Garcia, Jose, Gil-Herrera, Juana, Gutierrez, Antonio, Jarque, Isidro, Juan, Manel, Lendinez, Francisco, Llobet, Pilar, Lopez, Monica, Lopez de la Guia, Ana, Lopez-Hoyos, Marcos, Martin-Nalda, Andrea, Martinez, Monica, Melero, Josefa, Mendez-Echevarria, Ana, Moral, Pedro, Neth, Olaf, Nunez, Maria, Ocejo-Vinyals, Gonzalo, Ochoa-Grullon, Juliana, Olbrich, Peter, Ona, Raquel, Perez-Encinas, Manuel, Pons, Jaime, Rodriguez, Carmen, Sanchez, Berta, Luis Santos-Perez, Juan, Elena Seoane, Ma, Vlagea, Alexandru, ID Signal Oncohaematology Grp
Publikováno v:
Frontiers in Immunology
Scientia
Frontiers in Immunology, Vol 10 (2019)
Scientia
Frontiers in Immunology, Vol 10 (2019)
Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological manifestations, such as peripheral cytopenias or lymphoproliferative syndromes. Early diagnosis and management have signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf94051a54bb8f0f558f2ff342061532
https://doi.org/10.3389/fimmu.2019.00586
https://doi.org/10.3389/fimmu.2019.00586
Autor:
Rodríguez-Frade JM; Department of Immunology and Oncology, Chemokine Signaling Group, Centro Nacional de Biotecnología/CSIC, Madrid, Spain., González-Granado LI; Department of Pediatrics, 12 de Octubre Health Research Institute (imas12), Madrid, Spain.; Department of Public Health School of Medicine, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Santiago CA; X-ray Crystallography Unit, Centro Nacional de Biotecnología/Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Mellado M; Department of Immunology and Oncology, Chemokine Signaling Group, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 05; Vol. 15, pp. 1406532. Date of Electronic Publication: 2024 Jul 05 (Print Publication: 2024).
Autor:
Calvo-Apalategi A; Department of Immunology and Oncology, CNB-CSIC, Madrid, Spain., Nevado ML; Immunology Department, University Hospital 12 de Octubre, Madrid, Spain.; Hospital 12 Octubre Research Institute (Imas12), Madrid, Spain., Bravo-Gallego LY; Department of Immunology, La Paz University Hospital, Madrid, Spain., González-Granado LI; Immunology Department, University Hospital 12 de Octubre, Madrid, Spain.; Immunodeficiency Unit, Department of Pediatrics, University Hospital 12 de Octubre, Madrid, Spain., Allende LM; Immunology Department, University Hospital 12 de Octubre, Madrid, Spain.; Hospital 12 Octubre Research Institute (Imas12), Madrid, Spain.; School of Medicine, Complutense University of Madrid, Madrid, Spain., Pena RR; Department of Immunology, La Paz University Hospital, Madrid, Spain., López-Granados E; Department of Immunology, La Paz University Hospital, Madrid, Spain.; Lymphocyte Pathophysiology Group, La Paz Institute of Biomedical Research, IdiPAZ, Madrid, Spain., Reyburn HT; Department of Immunology and Oncology, CNB-CSIC, Madrid, Spain.
Publikováno v:
Immunology [Immunology] 2024 Jul; Vol. 172 (3), pp. 440-450. Date of Electronic Publication: 2024 Mar 21.
Autor:
Marín F; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain., Canet-Hermida J; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain., Bianchi V; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Chung J; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Foulkes W; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.; Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Pérez-Alonso V; Department of Pediatric Hematology and Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain., Domínguez-Pinilla N; Department of Pediatric Hematology and Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain., Sábado C; Department of Pediatric Hematology and Oncology, Hospital Vall d'Hebron, Barcelona, Spain., Vázquez-Gómez F; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Molinés A; Hematology and Hemotherapy Unit, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain., Fioravantti V; Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Carrasco E; Hereditary Cancer Genetics Group, Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Stengs L; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Edwards M; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Negm L; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Das A; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Pediatrics, University of Toronto, Toronto, ON, Canada., Aronson M; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, ON, Canada., Pastor Á; Laboratorio de Cáncer Hereditario, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain., Rueda D; Laboratorio de Cáncer Hereditario, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain., González-Granado LI; Immunodeficiencies Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 Octubre (i+12), Madrid, Spain., Tabori U; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Capellá G; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Hereditary Cancer Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Pineda M; Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Oncología (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Hereditary Cancer Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Publikováno v:
Clinical chemistry [Clin Chem] 2024 May 02; Vol. 70 (5), pp. 737-746.
Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity.
Autor:
Segura-Tudela A; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., López-Nevado M; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., Nieto-López C; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., García-Jiménez S; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., Díaz-Madroñero MJ; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain., Delgado Á; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain., Cabrera-Marante O; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., Pleguezuelo D; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., Morales P; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain., Paz-Artal E; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain.; School of Medicine, Complutense University of Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Gil-Niño J; Department of Internal Medicine, University Hospital, 12 de Octubre, Madrid, Spain., Marco FM; Unit of Immunology, University Hospital General Dr Balmis, Alicante, Spain., Serrano C; Department of Immunology, University Hospital Fundación Jiménez Díaz, Madrid, Spain., González-Granado LI; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain.; School of Medicine, Complutense University of Madrid, Madrid, Spain.; Unit of Immunodeficiencies, Department of Pediatrics, University Hospital, 12 de Octubre, Madrid, Spain., Quesada-Espinosa JF; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain.; Department of Genetics, University Hospital, 12 de Octubre, Madrid, Spain., Allende LM; Department of Immunology, University Hospital, 12 de Octubre, Avda. de Andalucía S/N, 28041, Madrid, Spain. luis.allende@salud.madrid.org.; Research Institute Hospital, 12 Octubre (imas12), Madrid, Spain. luis.allende@salud.madrid.org.; School of Medicine, Complutense University of Madrid, Madrid, Spain. luis.allende@salud.madrid.org.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Feb 16; Vol. 44 (3), pp. 61. Date of Electronic Publication: 2024 Feb 16.
Autor:
Canarutto D; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy., Asperti C; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Vavassori V; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Porcellini S; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Rovelli E; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Paulis M; Humanitas Clinical and Research Center IRCCS, Milan, Italy.; UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, Milan, Italy., Ferrari S; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Varesi A; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Fiumara M; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Jacob A; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Sergi Sergi L; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Visigalli I; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ferrua F; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy., González-Granado LI; Unidad de Immunodeficiencias Primarias y la Unidad de Hematología y Oncología Pediátrica, Instituto de Investigacíon Hospital 12 de Octubre, Madrid, Spain., Lougaris V; University of Brescia, Brescia, Italy., Finocchi A; Academic Department of Pediatrics (DPUO), Research Unit of Clinical Immunology and Vaccinology, Bambino Gesú Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy., Villa A; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.; UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, Milan, Italy., Radrizzani M; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Naldini L; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Università Vita-Salute San Raffaele, Milan, Italy.
Publikováno v:
The EMBO journal [EMBO J] 2023 Dec 01; Vol. 42 (23), pp. e114188. Date of Electronic Publication: 2023 Nov 02.
Autor:
Boast B; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md., Goel S; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md., González-Granado LI; Department of Pediatrics, Hospital 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), School of Medicine, Complutense University, Madrid, Spain., Niemela J; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md., Stoddard J; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md., Edwards ESJ; Department of Immunology, Monash University, and The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, Australia., Seneviratne S; Centre for Personalised Immunology and Division of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Spensberger D; ANU Gene Targeting Facility, Australian Phenomics Facility, John Curtin School of Medical Research, Australian National University, Canberra, Australia., Quesada-Espinosa JF; Department of Genetics, Hospital 12 de Octubre, Madrid, Spain., Allende LM; Department of Immunology, Hospital 12 de Octubre, Research Institute Hospital 12 de Octubre (i+12), Madrid, Spain., McDonnell J; Department of Pediatric Allergy and Immunology, Cleveland Clinic, Cleveland, Ohio., Haseley A; Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Lesmana H; Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio; Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Cleveland Clinic, Cleveland, Ohio., Walkiewicz MA; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Muhammad E; Hematology Laboratory, Carmel Medical Center, Haifa, Spain., Bosco JJ; Allergy, Asthma and Clinical Immunology Service, Alfred Hospital, Melbourne, Australia., Fleisher TA; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md., Cohen S; Allergy and Clinical Immunology Service, Department of Internal Medicine B, Lin and Carmel Medical Center, The Technion, Israel Institute of Technology, Haifa, Israel., Holland SM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., van Zelm MC; Department of Immunology, Monash University, and The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, Australia; Allergy, Asthma and Clinical Immunology Service, Alfred Hospital, Melbourne, Australia., Enders A; Centre for Personalised Immunology and Division of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia., Kuehn HS; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md., Rosenzweig SD; Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md. Electronic address: srosenzweig@nih.gov.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Sep; Vol. 152 (3), pp. 736-747. Date of Electronic Publication: 2023 Jun 03.